Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro

被引:632
作者
Zhu, YR
Peery, T
Peng, TM
Ramanathan, Y
Marshall, N
Marshall, T
Amendt, B
Mathews, MB
Price, DH
机构
[1] UNIV IOWA,DEPT BIOCHEM,IOWA CITY,IA 52242
[2] UNIV MED & DENT NEW JERSEY,DEPT BIOCHEM & MOL BIOL,NEWARK,NJ 07103
关键词
P-TEFb; transcription elongation factor; RNA polymerase II; HIV-1; Tat; transactivation;
D O I
10.1101/gad.11.20.2622
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P-TEFb is a key regulator of the process controlling the processivity-of RNA polymerase II and possesses a kinase activity that can phosphorylate the carboxy-terminal domain of the largest subunit of RNA polymerase II. Here we report the cloning of the small subunit of Drosophila P-TEFb and the finding that it encodes a Cdc2-related protein kinase. Sequence comparison suggests that a protein with 72% identity, PITALRE, could be the human homolog of the Drosophila protein. Functional homology was suggested by transcriptional analysis of an RNA polymerase II promoter with HeLa nuclear extract depleted of PITALRE. Because the depleted extract lost the ability to produce long DRB-sensitive transcripts and this loss was reversed by the addition of purified Drosophila P-TEFb, we propose that PITALRE is a component of human P-TEFb. In addition, we found that PITALRE associated with the activation domain of HIV-1 Tat, indicating that P-TEFb is a Tat-associated kinase (TAK). An in vitro transcription assay demonstrates that the effect of Tat on transcription elongation requires P-TEFb and suggests that the enhancement of transcriptional processivity by Tat is attributable to enhanced function of P-TEFb on the HIV-1 LTR.
引用
收藏
页码:2622 / 2632
页数:11
相关论文
共 58 条
[1]   ELONGIN (SIII) - A MULTISUBUNIT REGULATOR OF ELONGATION BY RNA-POLYMERASE-II [J].
ASO, T ;
LANE, WS ;
CONAWAY, JW ;
CONAWAY, RC .
SCIENCE, 1995, 269 (5229) :1439-1443
[2]  
Ausubel FA, 1995, CURRENT PROTOCOLS MO
[3]   REGULATION OF TRANSCRIPTIONAL ELONGATION BY RNA-POLYMERASE-II [J].
BENTLEY, DL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (02) :210-216
[4]  
Blau J, 1996, MOL CELL BIOL, V16, P2044
[5]   BLOCKING OF TAT-DEPENDENT HIV-1 RNA MODIFICATION BY AN INHIBITOR OF RNA POLYMERASE-II PROCESSIVITY [J].
BRADDOCK, M ;
THORBURN, AM ;
KINGSMAN, AJ ;
KINGSMAN, SM .
NATURE, 1991, 350 (6317) :439-441
[6]   INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT ACTIVITY BY COEXPRESSION OF HETEROLOGOUS TRANS ACTIVATORS [J].
CARROLL, R ;
PETERLIN, BM ;
DERSE, D .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2000-2007
[7]   Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1 [J].
Chun, RF ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27888-27894
[8]   The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme [J].
Cujec, TP ;
Cho, H ;
Maldonado, E ;
Meyer, J ;
Reinberg, D ;
Peterlin, BM .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :1817-1823
[9]   DOES HIV-1 TAT INDUCE A CHANGE IN VIRAL INITIATION RIGHTS [J].
CULLEN, BR .
CELL, 1993, 73 (03) :417-420
[10]   Reversible phosphorylation of the C-terminal domain of RNA polymerase II [J].
Dahmus, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19009-19012